OSTENTUS THERAPEUTICS
Ostentus Therapeutics is a biotechnology company investigating the activity, efficacy, and safety of novel natural compounds in the treatment of different types of cancer and leukemia through rigorous pharmacological testing. Ostentus Therapeutics was founded in 2021 and is based in Newport Beach, California, United States.
OSTENTUS THERAPEUTICS
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2021-05-01
Address:
Newport Beach, California, United States
Country:
United States
Website Url:
http://www.ostentustherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(+1) 714 658 8866
Email Addresses:
[email protected]
Total Funding:
100 K USD
Similar Organizations
Abelian Therapeutics
Abelian Therapeutics is a biotechnology company which engages in harnessing factors in brain disease.
BrainTrust BIO
BrainTrust BIO is a biotechnology company that focuses on riluzole administered by intrathecal infusion for the treatment of ALS.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Ci Therapeutics
Ci Therapeutics is a cannabis company that brings cannabis formulations to the market.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Eureka Therapeutics
Eureka Therapeutics is a biotechnology company focusing on immunotherapies for the treatment of cancer.
GenID Solutions
GenID Solutions is a company that is producing methods in treating cancer early on.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
PIC Therapeutics
PIC Therapeutics is a biotechnology company focused on transforming the treatment of cancer.
Qing Bile Therapeutics
Qing Bile Therapeutics is a biotechnology company that treats cholestatic and metabolic diseases using a type of bile acid they identified.
Remix Therapeutics
Remix Therapeutics is a biotechnology company.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Current Employees Featured
Founder
Official Site Inspections
http://www.ostentustherapeutics.com
- Host name: 46.202.145.38
- IP address: 46.202.145.38
- Location: Ukraine
- Latitude: 50.4522
- Longitude: 30.5287
- Timezone: Europe/Kiev
More informations about "Ostentus Therapeutics"
Home - Ostentus
/*! elementor - v3.5.6 - 28-02-2022 */ .elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-headingSee details»
About us - Ostentus Therapeutics
Ostentus Therapeutics, Inc.® (Ostentus Therapeutics) is a startup biotechnology company investigating the activity, efficacy, and safety of its novel natural compounds in the treatment of …See details»
Ostentus Therapeutics - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (+1) 714 658 8866 Ostentus Therapeutics is a biotechnology company investigating the activity, efficacy, and safety of …See details»
Ostentus Therapeutics - Overview, News & Similar companies
Www.ostentustherapeutics.com. Revenue <$5 Million. Industry Hospitals & Clinics Healthcare . Recent News & Media. No recent news or media. Overview ; Who is Ostentus Therapeutics. …See details»
Ostentus Therapeutics | Company Profile | Pharmacompass.com
Company Profile of Ostentus TherapeuticsSee details»
Ostentus Therapeutics, Inc. - Drug pipelines, Patents, Clinical trials ...
Explore Ostentus Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news, and 2 literature, Disease Domain:Neoplasms, Hemic and ...See details»
Ostentus Therapeutics Inc. - VentureRadar
Website: https://ostentustherapeutics.com/ Develops novel natural compounds for cancer and leukemia treatment, focusing on efficacy and safety through rigorous ...See details»
Investors - Ostentus - Ostentus Therapeutics
William Graff E-mail: [email protected] Call us. 949-274-4761. Email us. [email protected]See details»
Ostentus Therapeutics, Inc.: Drug pipelines, Patents, Clinical trials ...
Explore Ostentus Therapeutics, Inc. with its drug pipeline, therapeutic area, technology platform, .See details»
Ostentus Therapeutics:Company Profile & Technical …
Ostentus Therapeutics is a company that provides Natural compound and more. Ostentus Therapeutics is headquartered in United States California.See details»
Ostentus Therapeutics - Org Chart, Teams, Culture & Jobs - The Org
View Ostentus Therapeutics' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Ostentus Therapeutics - PitchBook
Ostentus Therapeutics General Information Description. Operator of a plant-derived treatments company intended to treat a multitude of cancers. The company uses a proprietary process to …See details»
Ostentus Therapeutics - Products, Competitors, Financials, …
Headquarters Location. 120 Newport Center Drive . Newport Beach, California, 92660, United States. 949-274-4761See details»
Ostentus Therapeutics, Inc., and City of Hope to Continue Studies …
May 31, 2023 NEWPORT BEACH, Calif.--(BUSINESS WIRE)--Ostentus Therapeutics, Inc., announced today that it has entered into a second Sponsored Research Agreement with City …See details»
Biography William Graff - Ostentus - ostentustherapeutics.com
Primary Specialty: EconomicsExperience: 35 Years. William Graff founded Ostentus in May 2021 and is a director and major shareholder inSee details»
Ostentus Therapeutics, Inc., and City of Hope to Initiate ... - BioSpace
Jan 27, 2022 NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- Ostentus Therapeutics, Inc., has entered into a Sponsored Research Agreement with City of Hope, a world-renowned cancer …See details»
Ostentus Therapeutics, Inc., and City of Hope to Initiate Studies of ...
Jan 27, 2022 William Graff (English/Spanish) [email protected] 1 (714) 658-8866 Contacts William Graff (English/Spanish) [email protected] 1 (714) 658 …See details»
R&D - Ostentus
Renowned oncologist-professor Dr. Guido Marcucci is one of Ostentus Therapeutics’ founders; under his expert lead we have been taking our plant- derived compounds and submitting them …See details»
OST-01 - Drug Targets, Indications, Patents - Synapse - Patsnap
Inactive Organization-Drug Highest Phase Preclinical. First Approval Date-Regulation-Related. 100 Clinical Results ... View source version on businesswire.com: Contacts William Graff …See details»
Research Timeline - Ostentus
Ostentus Therapeutics has entered into a few Sponsored Research Agreements with City of Hope, a world-renowned cancer treatment and research organization and a National Cancer …See details»